Statistics

Total Visits

Views
Verteporfin photodynamic therapy combined with intravitreal ranibizumab for polypoidal choroidal vasculopathy controversy concerning long-term followup.42

Select a period of time:

Number of views in the range

Views
Verteporfin photodynamic therapy combined with intravitreal ranibizumab for polypoidal choroidal vasculopathy controversy concerning long-term followup.26

Views

Views
October 20240
November 20240
December 20240
January 20257
February 20254
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States6
United Kingdom5
 

Top cities views

Views
Los Angeles2
London2
Boardman1
Buffalo1
Dallas1